MG
CELL

Michael Gelband’s PhenomeX Inc. Common Stock CELL Stock Holding History

Michael Gelband’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,676
Closed -$133K – 2624
2022
Q1 		$133K Sell
18,676
-20,682
-53% -$171K ﹤0.01% 1973
2021
Q4 		$716K Sell
39,358
-9,974
-20% -$215K 0.01% 1240
2021
Q3 		$965K Buy
+49,332
New +$1.88M 0.01% 1045

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Michael Gelband's CELL Position: Q2 2022 in Review

Michael Gelband sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 18,676 shares — an estimated $133K sold.

Michael Gelband first reported a position in CELL in Q3 2021 and held it in 3 quarters. The position peaked at $965K in Q3 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • Michael Gelband reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Michael Gelband sold 18,676 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $133K.
  • Michael Gelband first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Michael Gelband's PhenomeX Inc. Common Stock position peaked at $965K in Q3 2021.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on ExodusPoint Capital Management's 13F filing for Q2 2022, filed 22 Aug 2022.